RHUMBLINE ADVISERS - ENZO BIOCHEM INC ownership

ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 83 filers reported holding ENZO BIOCHEM INC in Q1 2021. The put-call ratio across all filers is 4.25 and the average weighting 0.3%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of ENZO BIOCHEM INC
ValueSharesWeighting
Q1 2021$259,000
+32.8%
75,155
-3.1%
0.00%
Q4 2020$195,000
+35.4%
77,575
+13.6%
0.00%
Q3 2020$144,000
-17.2%
68,266
-12.1%
0.00%
Q2 2020$174,000
-4.4%
77,704
+8.3%
0.00%
Q1 2020$182,000
-3.7%
71,7440.0%0.00%
Q4 2019$189,000
-27.0%
71,744
-0.4%
0.00%
Q3 2019$259,000
+16.1%
72,005
+8.6%
0.00%
Q2 2019$223,000
+37.7%
66,290
+11.6%
0.00%
Q1 2019$162,000
-3.6%
59,387
-1.9%
0.00%
Q4 2018$168,000
-1.2%
60,542
+46.4%
0.00%
Q3 2018$170,000
-25.8%
41,361
-6.4%
0.00%
Q2 2018$229,000
+3.6%
44,211
+9.8%
0.00%
Q1 2018$221,000
-34.4%
40,256
-2.6%
0.00%
-100.0%
Q4 2017$337,000
-35.3%
41,331
-17.0%
0.00%0.0%
Q3 2017$521,000
-4.2%
49,777
+1.1%
0.00%0.0%
Q2 2017$544,000
+45.8%
49,252
+10.6%
0.00%0.0%
Q1 2017$373,000
+25.6%
44,532
+4.1%
0.00%0.0%
Q4 2016$297,000
+45.6%
42,770
+7.0%
0.00%0.0%
Q3 2016$204,000
-12.4%
39,985
+2.6%
0.00%0.0%
Q2 2016$233,000
+124.0%
38,985
+11.0%
0.00%
Q1 2015$104,000
-17.5%
35,115
+24.0%
0.00%
Q4 2014$126,000
-11.3%
28,315
+3.0%
0.00%
Q3 2014$142,000
-1.4%
27,4900.0%0.00%
Q2 2014$144,00027,4900.00%
Other shareholders
ENZO BIOCHEM INC shareholders Q1 2021
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 2,436,771$7,822,00010.43%
VIEX Capital Advisors, LLC 1,736,087$5,573,0008.96%
HARBERT FUND ADVISORS, INC. 5,175,913$16,615,0004.19%
AMH Equity Ltd 596,742$1,916,0002.66%
Potomac Capital Management, Inc. 208,000$668,0000.59%
Agate Pass Investment Management, LLC 24,292$78,0000.05%
RBF Capital, LLC 250,359$804,0000.05%
KEMPNER CAPITAL MANAGEMENT INC. 25,475$82,0000.05%
Corsair Capital Management 58,657$188,0000.04%
BOOTHBAY FUND MANAGEMENT, LLC 319,500$1,026,0000.02%
View complete list of ENZO BIOCHEM INC shareholders